NewAmsterdam Pharma (NAMS) Shares Outstanding (2021 - 2026)
NewAmsterdam Pharma (NAMS) reported Shares Outstanding of 123.37 million for Q2 2026, up 4.1% from 118.56 million a year earlier and up 1.4% from the prior quarter.
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) Shares Outstanding (2021 - 2026) Analysis & Trends
For FY2025, NewAmsterdam Pharma posted Shares Outstanding of 118.42 million, up 25.5% from FY2024.
- Shares Outstanding has increased for five consecutive years, with a five-year compound annual growth rate of 61.9% (FY2020 to FY2025).
- By year, Shares Outstanding came in at 94.36 million in FY2024 (+14.8%), 82.16 million in FY2023 (+0.7%), 81.56 million in FY2022 (+238.0%) and 24.13 million in FY2021 (+126.5%).
- The Q2 2026 figure ranks as the highest quarterly Shares Outstanding in data going back to Q4 2021.
- Year over year, Shares Outstanding has now increased in each of the last 11 quarters, with growth averaging 18.3% over the last eight quarters.
- The year-over-year growth in Shares Outstanding has ranged between 0.7% (Q4 2023) and 238.0% (Q4 2022) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at 121.72 million (Q1 2026), 118.42 million (Q4 2025) and 119 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.70 Mn |
| 10 | NewAmsterdam Pharma | 2.86 Bn | 2.86 Bn | - | 123.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 123.37 Mn |
| Mar 31, 2026 | 121.72 Mn |
| Dec 31, 2025 | 118.42 Mn |
| Sep 30, 2025 | 119.00 Mn |
| Jun 30, 2025 | 118.56 Mn |
| Mar 31, 2025 | 116.12 Mn |
| Dec 31, 2024 | 94.36 Mn |
| Sep 30, 2024 | 94.75 Mn |
| Jun 30, 2024 | 94.71 Mn |
| Mar 31, 2024 | 88.38 Mn |
| Dec 31, 2023 | 82.16 Mn |
| Sep 30, 2023 | 82.47 Mn |
| Jun 30, 2023 | 82.06 Mn |
| Mar 31, 2023 | 81.63 Mn |
| Dec 31, 2022 | 81.56 Mn |
| Dec 31, 2021 | 24.13 Mn |
API Access
NewAmsterdam Pharma Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();